114.26%. The major causes of significant change are as follows: Unit : Million Baht Operating results of the Company For the Q1/2018 ended March 31, 2018 2017 Changes % Revenues : Revenues from sales and

is Baht 158.10 million in comparison with net profit of Baht 131.83 million for the same period previous year, an increase of Baht 26.27 million or 19.93%. The major causes of significant change are as

increase the normal capacity during off peak power usage in 4th Quarter of 2017. - Gain from debt restructuring was achieved of THB 734 million some portion resulting from debt-to-equity conversion scheme in

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1

value will be realized in profit and loss statement in such period. In 1Q2020, the significant change in fair value of derivatives the Company has was from the conversion option embedded in convertible

conversion scheme in according to the resolution approval from the Extra Ordinary Shareholders’ meeting no. 1/2017 on 30th August 2017 by newly issuing ordinary shares of the Company to pay the net trade debts

-to-equity conversion scheme in according to the resolution approval from the Extra Ordinary Shareholders’ meeting no. 1/2017 on 30th August 2017 by newly issuing ordinary shares of the Company to pay

?Bangkok, August 4, 2014 ? The SEC will allow commercial banks to offer for sale to retail investors, Basel III tier 2 instruments with condition of conversion to equity and specified floor

useful lives with reference to the Health Study Report from an independent engineering expert and the repair and maintenance of buildings, machinery and equipment. This is considered the Change in